Molecular Medicine Research Center, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Molecular Medicine Research Center, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
Gene. 2020 Jun 5;742:144577. doi: 10.1016/j.gene.2020.144577. Epub 2020 Mar 18.
Gastric cancer is a complex heterogeneous disease which is the fourth prevalent malignancy worldwide. Although, several diagnosis and treatment are available for the gastric cancer patients, however the malignancy is still the third leading cause of cancer-related death in the world. Beside the genetic and environmental factors, epigenetic alterations are also involved in the emergence of gastric cancer. Epigenetics alterations are heritable changes which regulate gene expression without occurring changes in DNA sequence. Epigenetic changes mostly include DNA methylation, histon post-translational modifications, chromatin remodeling and non-coding RNAs. Among the mentioned epigenetic modifications, DNA methylation is a major epigenetic process that plays a key role in different stages of evolution and cancer development. In this review, we address all types of related epigenetic modifications in gastric cancer by focus on DNA methylation by reviewing the recent literatures. Understanding of molecular mechanisms of epigenetics alterations in gastric cancer development helps researchers to identify new epigenetic drugs against the malignancy.
胃癌是一种复杂的异质性疾病,是全球第四大常见恶性肿瘤。尽管有多种诊断和治疗方法可用于胃癌患者,但这种恶性肿瘤仍然是全球癌症相关死亡的第三大主要原因。除了遗传和环境因素外,表观遗传改变也参与了胃癌的发生。表观遗传改变是一种可遗传的变化,它调节基因表达而不改变 DNA 序列。表观遗传改变主要包括 DNA 甲基化、组蛋白翻译后修饰、染色质重塑和非编码 RNA。在提到的表观遗传修饰中,DNA 甲基化是一种主要的表观遗传过程,在进化和癌症发展的不同阶段发挥关键作用。在这篇综述中,我们通过回顾最近的文献,主要关注 DNA 甲基化,讨论了胃癌中所有类型的相关表观遗传修饰。对胃癌发生中表观遗传改变的分子机制的理解有助于研究人员识别针对这种恶性肿瘤的新型表观遗传药物。